Skip to content

Esketamine: all studies

Page 47 of 123: studies 461 to 470 of 1,226, newest first. Back to the esketamine overview

Research

Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group.

Current Neuropharmacology 2025 Gianluca Rosso, Giacomo d'Andrea, Stefano Barlati et al. 23 citations

Data on long-term treatment with Esketamine Nasal Spray (ESKNS) in real-world patients with treatment resistant depression (TRD) is scarce. The primary aim of the study is to evaluate the effectiveness and tolerability of ESK-NS treatment at 6 and 12-month follow-ups. This is part of an observational, retrospective, multicentric Italian study (REAL-ESK study). Subjects for the present study...

Is there a risk of esketamine misuse in clinical practice?

Therapeutic advances in drug safety 2025 Carlos Roncero, Milton Merizalde-Torres, Néstor Szerman et al. 11 citations

In 2019, intranasal esketamine gained approval as a promising therapy for those individuals grappling with treatment-resistant depression. Both clinical trials and real-world studies have underscored its efficacy in alleviating and remitting depressive symptoms, with sustained benefits observed for nearly 4.5 years. As the S-enantiomer of ketamine, esketamine's dosing guidelines and strict...

Effects of esketamine on postoperative pain and inflammatory factors in children undergoing tonsillectomy and adenoidectomy.

Minerva anestesiologica 2025 Yuchang Zhu, Xujian Wang, Lifeng Wang et al. 3 citations

This study aimed to observe the effect of esketamine on postoperative pain and inflammatory factors in children undergoing tonsillectomy and adenoidectomy. Eighty children scheduled for tonsillectomy and adenoidectomy were randomly divided into two groups using a random number table: an esketamine group (S-ketamine group, N.=40) and a control group (control group, N.=40). The primary outcome...

DOI: 10.23736/S0375-9393.24.18277-6 (opens in new tab) Full text (opens in new tab) Pediatric_medicine Pain_management Anesthesiology Surgical_recovery +1

Effective doses of remimazolam and esketamine combined with remifentanil for endotracheal intubation without muscle relaxants in pediatric patients.

Frontiers in Pharmacology 2025 Jinming Chen, Ying Mai, Xiaolei Cheng et al. 5 citations

The combination of remimazolam and esketamine effectively alleviates adverse hemodynamic effects, such as tachycardia and hypertension, during intubation. However, the dosage for achieving optimal intubation conditions when co-administered with remifentanil remains unestablished. Therefore, this study aimed to determine the effective doses of remimazolam and esketamine for endotracheal...

DOI: 10.3389/fphar.2025.1558966 (opens in new tab) Full text (opens in new tab) Esketamine Dixon’s up-and-down method Effective dose Remimazolam +6

Ascorbic Acid and Esketamine for Mental Disorders in Women with Miscarriage: A Randomized Controlled Double-Blind Trial Protocol.

Neuropsychiatric Disease and Treatment 2025 Zhaojuan Ke, Ying Zhang, Binyang Cai et al. 1 citation

Pregnancy leads to vulnerabilities and susceptibilities to mental disorders. Miscarriage, as an adverse pregnancy outcome, and following curettage for treatment, add the risks of further psychiatric disorders, including depression, anxiety, insomnia, etc., and current approaches to prevention are unsatisfactory. Ketamine and its S-enantiomer esketamine can prevent postpartum depression, and...

Effect of Esketamine Compared with Sufentanil Combined with Propofol in Patients Undergoing First Trimester Surgical Abortion: A Randomized, Double-Blinded Clinical Trial.

Drug Design, Development and Therapy 2025 Yingchao Guan, Haochen Wang, Xiaojing Cong et al.

We explored whether esketamine anesthesia during first-trimester surgical abortion can reduce intraoperative hemodynamic fluctuations and improve patients' respiratory function. A total of 197 patients who underwent a first-trimester surgical abortion were included in the analysis. Patients were randomly assigned to either the esketamine anesthesia group (group E, n=98) or sufentanil anesthesia...

Feasibility of Closed-Loop TCI Based on New EEG Baseline in the Presence of Low Dose of Esketamine: A Randomized Controlled Equivalence Trial.

Drug Design, Development and Therapy 2025 Xiaoshan Li, Shengchao Li, Chanyan Xu et al. 3 citations

This research aimed to quantify the impact of low dose of esketamine on BIS and validate the feasibility of closed-loop TCI system based on the new BIS baseline with low dose of esketamine. This study consisted of two phases. The first phase was to quantify the impact of a low dose of esketamine (0.2mg kg-1 bolus, 5μg kg-1 min-1 infusion for 30min) on BIS and establish a new BIS baseline for...

DOI: 10.2147/DDDT.S508264 (opens in new tab) Full text (opens in new tab) Esketamine Closed-loop controlled system Depth of anesthesia New bis baseline +6

Case Report: Successful management of psychogenic non-epileptic seizures with intranasal esketamine.

Frontiers in Psychiatry 2025 Muneeb Hashmi, Padmasini Mugunthan, Priyal Jain et al. 2 citations

Psychogenic non-epileptic seizures (PNES), or functional seizures (FS), are episodes that resemble epileptic seizures but may be psychological in origin. Unlike epileptic seizures, which are linked to abnormal electrical activity in the brain, functional seizures may be associated with psychological and/or physical distress, and do not show the same electrical patterns on an...

Effects of Esketamine Versus Remifentanil on Hemodynamics and Prognosis in Patients with Septic Shock Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial.

Drug Design, Development and Therapy 2025 Yuting Li, Hongxiang Li, Feng Zhang et al. 3 citations

Analgesics and sedatives may affect the hemodynamics of patients with septic shock and produce adverse reactions. The purpose of this study is to compare the hemodynamic effects and prognosis of esketamine and remifentanil in combination with propofol in patients with septic shock receiving invasive mechanical ventilation. In this single-center, prospective, randomized, controlled pilot study,...

DOI: 10.2147/DDDT.S520252 (opens in new tab) Full text (opens in new tab) Esketamine Critical care medicine Invasive mechanical ventilation Norepinephrine +4

Effect of subclinical esketamine on NLRP3 and cognitive dysfunction in elderly ischemic stroke patients.

Open medicine (Warsaw, Poland) 2025 Lang Wang, Baoxin Ma, Jianping Zhang 1 citation

This study investigates the effects of subclinical doses of esketamine on serum NLRP3 levels and early cognitive dysfunction in elderly ischemic stroke patients after neurointerventional procedures under general anesthesia. A prospective cohort study included 120 elderly ischemic stroke patients undergoing general anesthesia from January 2022 to September 2023. The esketamine group received...